Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

45.68 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Exact Sciences (EXAS) Q2 2024 Earnings Call Transcript
EXAS earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exact Sciences Stock Climbs After Strong Q2 Results
Exact Sciences shares are trading higher after the company reported its second-quarter financial results Wednesday. Here's a look at the details from the report: 
Via Benzinga
Exact Sciences Announces Second-Quarter 2024 Results
From Exact Sciences Corp.
Via Business Wire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The strugglingh stock investor did a little bit of shopping on Tuesday, adding to some of her existing positions. 
Via The Motley Fool
FDA Greenlights Guardant Health's Shield Blood Test, Analyst Cautious on Adoption
FDA approves Guardant Health's Shield blood test for colorectal cancer screening in adults 45+, marking the first FDA-approved blood test as a primary CRC screening option. Shield meets Medicare... 
Via Benzinga
Peeling Back The Layers: Exploring Exact Sciences Through Analyst Insights
 
Via Benzinga
Expert Outlook: Exact Sciences Through The Eyes Of 5 Analysts
 
Via Benzinga
How Is The Market Feeling About Exact Sciences?
 
Via Benzinga
Goldman Sachs Says Buy These 3 Stocks for Double-Digit Returns
The investment banking firm says these companies are among the best stocks to buy and have some strong tailwinds behind them. 
Via InvestorPlace
This Cathie Wood Growth Stock Could Soar by 93%, According to Wall Street
Investors shouldn't rush to buy the stock based on rosy short-term price targets. 
Via The Motley Fool
Exact Sciences schedules second quarter 2024 earnings call
From Exact Sciences Corp.
Via Business Wire
The 3 Best Personalized Medicine Stocks to Buy in July 2024
Explore promising personalized medicine stocks poised for growth as the industry expands, driven by advancements in genomic technologies. 
Via InvestorPlace
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
 
Via Benzinga
Mainz Biomed’s ColoAlert Potentially Puts It On A Similar Track As Big Name Cancer Screening Stocks
Mainz Biomed’s ColoAlert Potentially Puts It On A Similar Track As Big Name Cancer Screening Stocks 
Via News Direct
Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests
Myriad Genetics Inc. (NASDAQ: MYGN) is a leader in genetic testing and precision medicine. The company offers a wide variety of genetic tests including 
Via MarketBeat
Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns
Jefferies Financial Group sees these three companies as prime candidates among stocks for double-digit returns. 
Via InvestorPlace
Is It Time to Buy May's Worst-Performing Nasdaq Stocks?
These two Nasdaq stocks are significantly cheaper today than they were just one month ago. 
Via The Motley Fool
Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness
On Monday, Cathie Wood-led Ark Invest made a significant move by reducing its holdings in Robinhood Markets Inc (NASDAQ:HOOD). This decision came amidst a period of market fluctuations and followed a... 
Via Benzinga
Cathie Wood-Led Ark Invest Buys $9.9M Worth Of Amazon Shares, Also Picks Up Reddit Stock
 
Via Benzinga
Top 4 Health Care Stocks That Are Preparing To Pump This Month
 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Exact Sciences to Participate in June Investor Conferences
From Exact Sciences Corp.
Via Business Wire
Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns
We're heading into our third year of this raging bull market, and there doesn't appear to be any end in sight for these high-return stocks. 
Via InvestorPlace
Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test
The companies are likely to soon battle it out in the colon cancer screening market. 
Via Investor's Business Daily
Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
From Exact Sciences Corp.
Via Business Wire
Exact Sciences Earns 2024 Great Place To Work® Certification™
From Exact Sciences Corp.
Via Business Wire
Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy
From Exact Sciences Corp.
Via Business Wire
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024
Discover three biotech stocks handpicked by Cathie Wood, offering groundbreaking therapies and substantial growth potential. 
Via InvestorPlace
Stocks Rebound As Rising Jobless Claims Sustain Rate-Cut Hopes, Dollar Falls, Gold Rallies: What's Driving Markets Thursday?
Wall Street is seeing a day of gains as all major indices traded in the green around noon in New York, driven by a surprising uptick in unemployment claims prompting speculation over Federal Reserve... 
Via Benzinga
Topics Economy
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS